Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Waxman Becomes Key Legislator On Biopharma Issues With House Flip

This article was originally published in The Pink Sheet Daily

Executive Summary

The congressman will likely support follow-on biologics legislation and other reforms sought by the generic industry as chairman of Government Reform Committee and as a senior member of Energy & Commerce Committee.

You may also be interested in...



Democratic Sen.-Elect Sherrod Brown Has Extensive Healthcare Experience

The Ohio congressman will probably champion generic industry issues as a likely member of the Senate Health Committee.

Democratic Sen.-Elect Sherrod Brown Has Extensive Healthcare Experience

The Ohio congressman will probably champion generic industry issues as a likely member of the Senate Health Committee.

U.S. Policy Missteps Could Send Biotech Overseas, Biogen Idec CEO Warns

China, India and Singapore stand to benefit, Mullen tells Massachusetts biotech investors conference.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134043

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel